Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001919532 | SCV002188264 | uncertain significance | not provided | 2021-11-11 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with NDUFS2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 138 of the NDUFS2 protein (p.Arg138Trp). |
Laboratory of Inherited Metabolic Diseases, |
RCV003107898 | SCV003762156 | uncertain significance | Mitochondrial complex 1 deficiency, nuclear type 6 | 2023-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003107898 | SCV004048804 | uncertain significance | Mitochondrial complex 1 deficiency, nuclear type 6 | 2023-04-11 | criteria provided, single submitter | clinical testing |